China moves into the lead in growth rate for PACS

Article

Rising standards of patient care are driving PACS adoption among top-quality medical facilities in Japan, South Korea, and China, making the Asia-Pacific region the third largest PACS market after the U.S. and Europe, according to an industry report from Frost & Sullivan.

Rising standards of patient care are driving PACS adoption among top-quality medical facilities in Japan, South Korea, and China, making the Asia-Pacific region the third largest PACS market after the U.S. and Europe, according to an industry report from Frost & Sullivan.

The annual average PACS growth rate of 20% in China expected over the next five years is the highest in the world. The growth rate in Japan and South Korea is half that of China.

The surging interest seen in Asia presents new opportunities and challenges for multinational PACS manufacturers. To successfully participate in the region, PACS vendors must adapt their technology to meet specific characteristics demanded by each country.

China, Southeast Asia, and South Korea typically use radiology information and hospital information systems that do not comply with the U.S. HL7 standard. Instead, these countries opt for a variety of local language-based systems that operate on 2-bit characters.

On the other hand, the U.S. patient care model is already popular in areas such as Malaysia, Singapore, Australia, New Zealand, and Hong Kong.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.